---
title: "Rifaximin - Hepatic Encephalopathy"
sidebar: mydoc_sidebar
permalink: db01220-mesh-d006501-1.html
toc: false 
---


Path ID: `DB01220_MESH_D006501_1`
{% include image.html url="images/db01220-mesh-d006501-1.png" file="db01220-mesh-d006501-1.png" alt="db01220-mesh-d006501-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C042734 | Rifaximin | Drug |
| UniProt:P0A8V2 | DNA-directed RNA polymerase subunit beta | Protein |
| GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | MolecularActivity |
| GO:0006351 | Transcription, DNA-templated | BiologicalProcess |
| NCBITaxon:2 | Bacteria | OrganismTaxon |
| MESH:D000641 | Ammonia | ChemicalSubstance |
| MESH:D006501 | Hepatic encephalopathy | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Rifaximin | DECREASES ACTIVITY OF | Dna-Directed Rna Polymerase Subunit Beta |
| Dna-Directed Rna Polymerase Subunit Beta | POSITIVELY REGULATES | Dna-Directed 5'-3' Rna Polymerase Activity |
| Dna-Directed 5'-3' Rna Polymerase Activity | POSITIVELY CORRELATED WITH | Transcription, Dna-Templated |
| Transcription, Dna-Templated | IN TAXON | Bacteria |
| Bacteria | PRODUCES | Ammonia |
| Ammonia | CONTRIBUTES TO | Hepatic Encephalopathy |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01220](https://go.drugbank.com/drugs/DB01220)
  - [https://en.wikipedia.org/wiki/Hepatic_encephalopathy#Causes](https://en.wikipedia.org/wiki/Hepatic_encephalopathy#Causes)
